STEMI in the cancer patient: Do not withhold primary PCI!
Cindy L GrinesPradyumna E TummalaJ Jeffrey MarshallPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2020)
Poor outcomes observed in cancer patients who sustain STEMI are due, in part, to advanced age, comorbidities, and underutilization of guidelines-based therapies. Coronary angiography in the cancer patient is more likely to demonstrate MINOCA, but the majority have critical disease and PCI success is similar to noncancer patients. We recommend primary PCI with stenting as the default strategy in STEMI patients with cancer.
Keyphrases
- percutaneous coronary intervention
- st elevation myocardial infarction
- st segment elevation myocardial infarction
- papillary thyroid
- antiplatelet therapy
- acute coronary syndrome
- coronary artery disease
- acute myocardial infarction
- squamous cell
- end stage renal disease
- case report
- atrial fibrillation
- chronic kidney disease
- newly diagnosed
- type diabetes
- prognostic factors
- metabolic syndrome
- adipose tissue
- functional connectivity
- weight loss
- skeletal muscle
- patient reported
- insulin resistance